Literature DB >> 10783328

mRNA expression patterns in different stages of asbestos-induced carcinogenesis in rats.

H Sandhu1, W Dehnen, M Roller, J Abel, K Unfried.   

Abstract

Human malignant mesotheliomas are induced almost exclusively by fibrous dusts. The nature of interactions between fibers and target cells, and the molecular mechanisms leading to tumorigenesis, are not yet understood. Here, the mRNA expression patterns at different stages of asbestos-induced carcinogenesis in rats were monitored by suppression subtractive hybridization (SSH) and array assay. Several genes were upregulated in pretumorous tissues from asbestos-treated rats, in asbestos-induced tumors and in cells treated with asbestos in vitro. The upregulation of the proto-oncogene c-myc, fra-1 and egfr in fiber-induced carcinogenesis was demonstrated at different stages of carcinogenesis. A possible role of Fra-1 as one of the dimeric proteins generating the AP-1 transcription factor was substantiated by its dose-dependent expression in mesothelial cells treated with asbestos in vitro. The upregulation of osteopontin (an extracellular matrix protein) and of zyxin and integrin-linked kinase (intracellular proteins associated with the focal adhesion contact), indicate that fibers may affect integrin-linked signal transduction and extracellular matrix proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783328     DOI: 10.1093/carcin/21.5.1023

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  12 in total

Review 1.  Cellular and molecular parameters of mesothelioma.

Authors:  Maria E Ramos-Nino; Joseph R Testa; Deborah A Altomare; Harvey I Pass; Michele Carbone; Maurizio Bocchetta; Brooke T Mossman
Journal:  J Cell Biochem       Date:  2006-07-01       Impact factor: 4.429

Review 2.  Diagnosis and prognosis-review of biomarkers for mesothelioma.

Authors:  Huan H Sun; Allen Vaynblat; Harvey I Pass
Journal:  Ann Transl Med       Date:  2017-06

Review 3.  Bioanalytical techniques for detecting biomarkers of response to human asbestos exposure.

Authors:  Clementina Mesaros; Andrew J Worth; Nathaniel W Snyder; Melpo Christofidou-Solomidou; Anil Vachani; Steven M Albelda; Ian A Blair
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.681

4.  Construction of a metastasis-associated gene subtracted cDNA library of human colorectal carcinoma by suppression subtraction hybridization.

Authors:  Li Liang; Yan-Qing Ding; Xin Li; Guang-Zhi Yang; Jun Xiao; Li-Chun Lu; Jin-Hua Zhang
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

5.  Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure.

Authors:  Stefan B Watzka; Florian Posch; Harvey I Pass; Raja M Flores; Gregory E Hannigan; David Bernhard; Michael Weber; Michael R Mueller
Journal:  Eur J Cardiothorac Surg       Date:  2012-10-07       Impact factor: 4.191

6.  Neoplastic-like transformation effect of single-walled and multi-walled carbon nanotubes compared to asbestos on human lung small airway epithelial cells.

Authors:  Liying Wang; Todd A Stueckle; Anurag Mishra; Raymond Derk; Terence Meighan; Vincent Castranova; Yon Rojanasakul
Journal:  Nanotoxicology       Date:  2013-05-28       Impact factor: 5.913

Review 7.  Malignant pleural mesothelioma.

Authors:  Anne S Tsao; Ignacio Wistuba; Jack A Roth; Hedy Lee Kindler
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

Review 8.  Progress in the application of DNA microarrays.

Authors:  E K Lobenhofer; P R Bushel; C A Afshari; H K Hamadeh
Journal:  Environ Health Perspect       Date:  2001-09       Impact factor: 9.031

9.  A mathematical model for suppression subtractive hybridization.

Authors:  Chetan Gadgil; Anette Rink; Craig Beattie; Wei-Shou Hu
Journal:  Comp Funct Genomics       Date:  2002

Review 10.  Mouse models for mesothelioma drug discovery and development.

Authors:  Kenneth P Seastedt; Nathanael Pruett; Chuong D Hoang
Journal:  Expert Opin Drug Discov       Date:  2020-12-31       Impact factor: 7.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.